Mirae Asset Global Investments’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.8K | Buy |
1,635
+185
| +13% | +$5.19K | ﹤0.01% | 1276 |
|
|
2025
Q1 | $33.5K | Buy |
1,450
+65
| +5% | +$1.5K | ﹤0.01% | 1314 |
|
|
2024
Q4 | $27.7K | Sell |
1,385
-84
| -6% | -$1.68K | ﹤0.01% | 1374 |
|
|
2024
Q3 | $36.7K | Buy |
1,469
+266
| +22% | +$6.65K | ﹤0.01% | 1353 |
|
|
2024
Q2 | $22.4K | Sell |
1,203
-19,732
| -94% | -$367K | ﹤0.01% | 1368 |
|
|
2024
Q1 | $276K | Buy |
20,935
+1,153
| +6% | +$15.2K | ﹤0.01% | 2145 |
|
|
2023
Q4 | $347K | Sell |
19,782
-1,154
| -6% | -$20.2K | ﹤0.01% | 2140 |
|
|
2023
Q3 | $364K | Buy |
20,936
+431
| +2% | +$7.49K | ﹤0.01% | 2044 |
|
|
2023
Q2 | $290K | Sell |
20,505
-879
| -4% | -$12.4K | ﹤0.01% | 2192 |
|
|
2023
Q1 | $230K | Buy |
21,384
+4,876
| +30% | +$52.5K | ﹤0.01% | 2276 |
|
|
2022
Q4 | $247K | Buy |
16,508
+3,532
| +27% | +$52.9K | ﹤0.01% | 2228 |
|
|
2022
Q3 | $167K | Buy |
+12,976
| New | +$167K | ﹤0.01% | 2394 |
|
|
2021
Q3 | – | Sell |
-526
| Closed | -$7K | – | 1761 |
|
|
2021
Q2 | $7K | Buy |
+526
| New | +$7K | ﹤0.01% | 1689 |
|